ALK Phosphorylation
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Therapeutic Effect of Crizotinib for Rearrangement-negative, High Phosphorylated ALK Patients (NCT05792644) | Harbin Medical University | 2018-01-01 |
Track ALK Phosphorylation automatically
Every clearance here is in the API, with alerts when new ones post.